LeMaitre to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced its participation in two investor conferences in August 2021. CFO JJ Pellegrino will present at the Canaccord Genuity 41st Annual Growth Conference on August 12 at 9:00 AM EDT and will also attend the Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16. LeMaitre specializes in devices and services for treating peripheral vascular disease, which impacts over 200 million people globally.
- None.
- None.
BURLINGTON, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the virtual Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12, 2021, at 9:00 AM EDT.
He is also scheduled to participate in the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Monday, August 16, 2021.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
FAQ
What are the dates of the investor conferences for LeMaitre Vascular in August 2021?
Who will present on behalf of LeMaitre Vascular at the investor conferences?
What is the primary focus of LeMaitre Vascular's business?
How many people are affected by peripheral vascular disease worldwide?
Where can I find more information about LeMaitre Vascular?
